Statute Details
- Title: MediShield Life Scheme (Disclosure of Information) Regulations 2017
- Act Code: MLSA2015-S458-2017
- Legislation Type: Subsidiary legislation (Regulations)
- Authorising Act: MediShield Life Scheme Act 2015 (Act 4 of 2015)
- Enacting Power: Section 34(1) of the MediShield Life Scheme Act 2015
- Citation: S 458/2017
- Commencement: 30 November 2017
- Maker: Permanent Secretary, Ministry of Health (Chan Heng Kee)
- Date Made: 11 August 2017
- Status: Current version as at 27 March 2026
- Key Provisions (Extract): Sections 2–3 (prescribed public schemes; healthcare-related public schemes); Section 4 (revocation)
What Is This Legislation About?
The MediShield Life Scheme (Disclosure of Information) Regulations 2017 (“Disclosure of Information Regulations”) are subsidiary rules made under the MediShield Life Scheme Act 2015. In plain terms, they identify which public schemes are treated as “prescribed public schemes” for the purposes of Part 5 of the MediShield Life Scheme Act 2015—specifically, the statutory framework governing disclosure of information connected to MediShield Life.
Although the Regulations are short, they play an important practical role. In Singapore’s healthcare financing landscape, multiple public schemes may support healthcare costs, disability care, elderly care, and related expenses. The Regulations ensure that, for disclosure purposes under the Act, the relevant public schemes are clearly categorised—so that information sharing can occur within the boundaries set by the Act.
From a legal practitioner’s perspective, the Regulations matter because they define the “universe” of schemes that can be treated as prescribed public schemes. That classification can affect whether and how personal or scheme-related information may be disclosed to administrators of those schemes, subject to the safeguards and conditions in the parent Act.
What Are the Key Provisions?
Section 1: Citation and commencement provides the formal identification of the Regulations and states that they come into operation on 30 November 2017. This matters for practitioners assessing whether disclosure-related processes were governed by these Regulations at a particular time, or whether an earlier regime applied.
Section 2: Prescribed public schemes is the core gateway provision. It states that the prescribed public schemes for the purposes of Part 5 of the Act are all healthcare-related public schemes. This is a broad formulation: it does not list every scheme by name. Instead, it sets a category-based approach—“healthcare-related public schemes”—which is then elaborated in Section 3.
Section 3: Healthcare-related public schemes expands on what counts as “healthcare-related public schemes” for disclosure purposes. It provides two limbs:
(a) all relevant public schemes; and
(b) all public schemes established by the Government or a public authority, and administered by the Ministry of Health, where the scheme provides any grant, subsidy or other benefit for specified categories of costs.
The second limb is particularly important because it ties the scope to both (i) the institutional characteristics of the scheme (established by Government or a public authority; administered by the Ministry of Health) and (ii) the type of benefit provided. The categories of costs covered include:
- (i) premiums for any healthcare or disability care insurance scheme;
- (ii) expenses for domestic help and care for disabled or elderly persons, or for devices and consumables for use in the care of such persons;
- (iii) expenses for step-down care as defined in section 2(1) of the Medical and Elderly Care Endowment Schemes Act (Cap. 173A);
- (iv) other healthcare expenses.
Practically, Section 3 is designed to capture not only direct medical expenses, but also adjacent healthcare and care-related costs that are commonly supported by public programmes. For example, support for insurance premiums, caregiving-related domestic help, and step-down care expenses are explicitly included. This breadth suggests that disclosure under Part 5 of the Act is intended to facilitate coordination across the healthcare financing ecosystem, rather than limiting disclosure to strictly clinical costs.
Section 4: Revocation revokes the earlier set of Regulations titled MediShield Life Scheme (Prescribed Public Scheme for Disclosure of Information) Regulations 2015 (G.N. No. S 526/2015). This indicates that the 2017 Regulations replaced the 2015 disclosure-prescription framework. For practitioners, revocation is relevant when reviewing historical disclosures, compliance documentation, or policy decisions made between 2015 and 2017.
How Is This Legislation Structured?
The Regulations are structured as a short instrument with four sections:
- Section 1 sets out the citation and commencement date.
- Section 2 defines the category of “prescribed public schemes” by reference to “all healthcare-related public schemes”.
- Section 3 defines “healthcare-related public schemes” by listing two categories: (a) all relevant public schemes; and (b) specified Ministry of Health–administered Government/public authority schemes that provide benefits for enumerated healthcare and care-related expenses.
- Section 4 revokes the 2015 Regulations.
Notably, the Regulations do not themselves set out the mechanics of disclosure (for example, who may disclose, to whom, and under what conditions). Instead, they operate as a classification and enabling instrument: they determine which schemes fall within the “prescribed” category for the disclosure regime in Part 5 of the MediShield Life Scheme Act 2015.
Who Does This Legislation Apply To?
While the Regulations are directed at the legal framework under the MediShield Life Scheme Act 2015, their practical effect is felt by parties involved in administering MediShield Life and the relevant public schemes. In general terms, the Regulations apply to:
- Administrators and relevant officers dealing with MediShield Life information under Part 5 of the Act; and
- Public schemes that fall within the definition of “prescribed public schemes” (as healthcare-related public schemes) for disclosure purposes.
Because Section 3 includes schemes established by Government or a public authority and administered by the Ministry of Health, the Regulations are particularly relevant to Ministry of Health–administered programmes and to “relevant public schemes” as that term is used in the Act’s framework. The breadth of “all relevant public schemes” and “all public schemes” meeting the criteria means that the scope can be wide and may evolve as new public schemes are established or existing ones are administered under the Ministry of Health.
Why Is This Legislation Important?
First, it clarifies the disclosure perimeter. In data-sharing regimes, the key legal question is often not only whether disclosure is permitted, but also whether the recipient scheme is within the class of schemes authorised by law. By prescribing the relevant public schemes, these Regulations reduce ambiguity and help ensure that disclosures under Part 5 of the MediShield Life Scheme Act 2015 are made to eligible scheme administrators.
Second, it supports cross-scheme coordination in healthcare financing. The explicit inclusion of premium support for healthcare/disability insurance, domestic help and care expenses for disabled or elderly persons, devices and consumables for care, and step-down care expenses indicates a policy intent: MediShield Life information may be used to facilitate the administration of broader healthcare-related benefits. This can improve administrative efficiency and potentially reduce duplication of information requirements for beneficiaries.
Third, it has compliance and risk implications for practitioners. When advising healthcare administrators, public scheme operators, or compliance teams, lawyers must consider whether a disclosure is permitted under the Act and whether the recipient scheme is “prescribed” under these Regulations. Failure to correctly identify whether a scheme falls within Section 2/3 could create legal risk, including challenges to the lawfulness of disclosure. Conversely, correct classification can support defensible compliance decisions and documentation.
Finally, it signals continuity with an earlier regime. The revocation of the 2015 Regulations means that, from 30 November 2017, the 2017 framework governs the prescribed public schemes for disclosure purposes. Practitioners reviewing historical cases or audits should ensure they apply the correct version for the relevant time period.
Related Legislation
- MediShield Life Scheme Act 2015 (Act 4 of 2015) — in particular, Part 5 (disclosure of information framework) and section 34(1) (power to make regulations)
- Shield Life Scheme Act 2015 — referenced in the statute metadata as part of the broader legislative ecosystem
- Elderly Care Endowment Schemes Act (Cap. 173A) — referenced for the definition of “step-down care” in Section 3(iii) of these Regulations
Source Documents
This article provides an overview of the MediShield Life Scheme (Disclosure of Information) Regulations 2017 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.